Evidence map›Paper›PMID 21930697›Full record

ArticleThe Journal of biological chemistry2011

Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?

Glen Kristiansen, Junmin Hu, Daniela Wichmann, Daniel P Stiehl, Michael Rose, Josefine Gerhardt, Annette Bohnert, Anette ten Haaf, Holger Moch, James Raleigh and 10 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Transcriptomic Profile of Canine Mammary Ductal Carcinoma.International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The role of myoglobin in epithelial cancers: Insights from transcriptomics.International journal of molecular medicine · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 4 countries.

Glen KristiansenInstitute of Pathology, University Hospital Bonn, 53127 Bonn, Germany. glen.kristiansen@ukb.uni-bonn.de
Junmin Hu
Daniela Wichmann
Daniel P Stiehl
Michael Rose
Josefine Gerhardt
Annette Bohnert
Anette ten Haaf
Holger Moch
James Raleigh
Mahesh A Varia
Patrick Subarsky
Francesca M Scandurra
Erich Gnaiger
Eva Gleixner
Anne Bicker
Max Gassmann
Thomas Hankeln
Edgar Dahl
Thomas A Gorr
University of Zurich · CHJohannes Gutenberg University Mainz · DERWTH Aachen University · DEUniversity Hospital of Zurich · CHInnsbruck Medical University · ATUniversity of North Carolina at Chapel Hill · USUniversität Innsbruck · ATUniversity Hospital Bonn · DEUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, immunohistochemical analysis of myoglobin (MB) in human breast cancer specimens has revealed a surprisingly widespread expression of MB in this nonmuscle context. The positive correlation with hypoxia-inducible factor 2α (HIF-2α) and carbonic anhydrase IX suggested that oxygen regulates myoglobin expression in breast carcinomas. Here, we report that MB mRNA and protein levels are robustly induced by prolonged hypoxia in breast cancer cell lines, in part via HIF-1/2-dependent transactivation. The hypoxia-induced MB mRNA originated from a novel alternative transcription start site 6 kb upstream of the ATG codon. MB regulation in normal and tumor tissue may thus be fundamentally different. Functionally, the knockdown of MB in MDA-MB468 breast cancer cells resulted in an unexpected increase of O(2) uptake and elevated activities of mitochondrial enzymes during hypoxia. Silencing of MB transcription attenuated proliferation rates and motility capacities of hypoxic cancer cells and, surprisingly, also fully oxygenated breast cancer cells. Endogenous MB in cancer cells is apparently involved in controlling oxidative cell energy metabolism, contrary to earlier findings on mouse heart, where the targeted disruption of the Mb gene did not effect myocardial energetics and O(2) consumption. This control function of MB seemingly impacts mitochondria and influences cell proliferation and motility, but it does so in ways not directly related to the facilitated diffusion or storage of O(2). Hypothetically, the mitochondrion-impairing role of MB in hypoxic cancer cells is part of a novel tumor-suppressive function.

Indexed as

Blotting, WesternBreast NeoplasmsCell HypoxiaCell LineCell Line, TumorCell MovementCell ProliferationFemaleHumansImmunohistochemistryMyoglobinReverse Transcriptase Polymerase Chain ReactionRNA InterferenceMyoglobin

Identifiers

PMID21930697
PMCPMC3234873
OpenAlexW2082107715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.